epairing bone defects resulting from trauma, tumors, or inflammation remains challenging for orthopedic surgeons. Current treatments for bone defects mainly include autografts and allografts. 1 However, these methods have several drawbacks, including limited availability and donor-site morbidity for autografts and issues related to immune responses, infection, and disease transmission for allografts. [2] [3] [4] [5] The application of tissueengineered bones overcomes these drawbacks and offers a new therapeutic strategy for repairing bone defects. When bone defects, particularly those that are large scale, are repaired by implantation of tissueengineered bones, angiogenesis is a necessary step before satisfactory bone regeneration is achieved. [6] [7] [8] The promotion of angiogenesis and vascularization of tissue-engineered bones remains a major challenge in clinical applications. The sources of autologous cells used to construct prevascularized tissue-engineered bones must fulfill several important prerequisites (eg, ease of acquisition, good expansion capacity, and stable endothelial cell [EC] phenotypes and osteoblast cell [OC] phenotypes) before these bones can be considered for clinical applications. 9 Bone marrow mesenchymal stem cell (BMSC)-derived ECs and OCs satisfy these prerequisites. 10 The repair of bone defects with vascularized tissueengineered bone has been reported in previous studies mainly focused on small animal experiments involving rats 8 and rabbits. 11 For better application in clinical practice, the repair of bone defects needs to be studied in larger animals.
In this study, the authors constructed prevascularized tissueengineered bone with BMSCderived OCs and BMSC-derived ECs co-cultured in porous ß-tricalcium phosphate ceramic (ß-TCP) in a perfusion bioreactor to repair bone defects in sheep. The hypothesis was that prevascularized, compared with nonvascularized, tissue-engineered bone could improve the repair of bone defects in a large animal.
Materials and Methods

Cell Isolation and Culture
Sheep BMSCs were isolated and expanded using a modification of a previously reported method. 12 Briefly, 20 mL of bone marrow aspirates was harvested through a bone marrow biopsy needle inserted through the iliac crest. Then, 2 mL of the bone marrow aspirates was immediately inoculated onto a 100-mm culture dish. The aspirates were cultured in a growth medium containing a-minimal essential medium (a-MEM; Invitrogen, Carlsbad, California) supplemented with 10% fetal bovine serum (FBS; Gibco, Carlsbad, California), 100 IU/ mL of penicillin, and 100 mg/ mL of streptomycin (Hyclone, Logan, Utah) at 37°C in a humidified 5% CO 2 incubator. After 3 days, nonadherent cells were removed by washing with phosphate-buffered saline, and adherent cells were further cultured in a-MEM until n the cutting edge 80% to 90% confluence. The remaining attached cells were mainly BMSCs. The obtained BMSCs were enzymatically lifted and subcultured at a density of 5×10 3 cells/ cm 2 . The second passage of BMSCs was used for this experiment.
Differentiation of Bone Marrow Mesenchymal Stem Cells
Bone marrow mesenchymal stem cells were induced to differentiate into osteoblasts in a-MEM supplemented with 10% FBS, 100 IU/mL of penicillin, 100 mg/mL of streptomycin, and osteogenic supplements consisting of 50 mg/mL of ascorbic acid, 10 mM of ß-glycerophosphate, and 10 nM of dexamethasone (all from Sigma, St. Louis, Missouri). 13 Cells from the second passage were used for the experiments. To promote the EC phenotype differentiation, BMSCs from the second passage were cultured on dishes coated with 1 µg/cm 2 of bovine fibronectin (Sigma) in EC growth medium (EGM2-MV; Clonetics Corp, Walkersville, Maryland) containing 0.4% human fibroblast growth factor with heparin, 0.04% hydrocortisone, 0.1% vascular endothelial growth factor (VEGF), 0.1% human recombinant insulin-like growth factor (R3-IGF-1), 0.1% ascorbic acid, and 5% FBS at 37°C in a humidified 5% CO 2 incubator. 11 Cells from the second passage were used for the experiments.
Scaffold Materials for Tissue Engineering
The critical-size porous cylindrical ß-TCP scaffold (Shanghai Bio-Lu Biomaterials Company Limited, Shanghai, China) used in this study had a homogeneous porosity of 75%, spherical pores 530±100 µm in diameter, and interconnections of 150±50 µm in diameter (Figure 1) . The cylinder has a diameter of 10 mm and a height of 30 mm, creating a blind end tunnel situated in the scaffold's center. The tunnel was 2.5 mm wide and 25 mm long.
Construction of TissueEngineered Bone
Equal volumes of BMSCderived OCs (2×10 6 cells/ mL) and BMSC-derived ECs (2×10 6 cells/mL) were mixed to construct the prevascularized tissue-engineered bones. The ß-TCP scaffold was immersed in the mixed cell suspension. To cause the cellular suspension to penetrate the scaffold, a vacuum (approximately 1.9×10
4 Pa) was generated by a pump for 1 minute, and the cells/ß-TCP construct was assembled to the perfusion bioreactor system, which has been previously described (Figure 2 ).
14 After 2 hours of cell attachment, 100 mL of osteogenic medium was added to the perfusion bioreactor system. After another 2 hours, the perfusion bioreactor system was turned on. The dynamic culture was performed for 14 days, and the medium was completely changed every 3 days. To construct the nonvascularized tissue-engineered bone, the ß-TCP scaffold was immersed in the BMSCderived OCs suspension (2×10 6 cells/mL) and subjected to dynamic culture for 14 days as described above. The perfusion flow rate was 1.5 mL/min in both groups.
Repair of Bone Defects in Sheep
Eight 2-year-old sheep weighing 50.0 to 62.0 kg were used in this study. Once the sheep were anesthetized, an approximately 4-cm lateral incision was made inferior to the greater trochanter along the right femur, exposing the proximal shaft of the femur ( Figure 3A) . A K-wire was drilled into the femoral neck inferior to the greater trochanter. A cannulated reamer with an outer diameter of 10 mm was drilled along the K-wire to create a bone defect approximately 3 cm deep (Figure 3B) . The constructed pre- n the cutting edge vascularized tissue-engineered bone was grafted into the bone defect, and then the incision was closed (Figures 3C-D) . The nonvascularized tissueengineered bone was grafted into the left femur. Postoperatively, 40,000 IU/kg of penicillin was administered for 5 days as antibacterial prophylaxis. Four sheep were sacrificed at 8 and 16 weeks postoperatively, and specimens were prepared for examination.
Gross View and Radiographic Examination
The animals' postoperative activities, food intake, and wound healing were observed. After sacrifice, the animals' bilateral femurs were removed and anteroposterior radiographs were obtained to observe bone healing. The status of bone repair and new bone formation were studied in samples collected through the original surgical site after radiographic examination.
Histological Observation and Histomorphometry
For histological analysis, the samples were fixed in 70% ethanol for 10 days and then dehydrated in a series of increasing graded ethanol, cleared with toluene, and embedded in methylmethacrylate. After polymerization, approximately 150-µm-thick sections were achieved via a Leica SP 1600 saw microtome (Leitz, Wetzlar, Germany). The sections were then ground and polished to approximately 50-µm thickness with an Exakt grinder (Exakt GmbH, Norderstedt, Germany). All sections were stained with Stevenel blue and van Gieson picrofuchsin. The ß-TCP scaffold could not be stained, but the bone tissue was stained red. The sections were examined with a Leica DM4000 B microscope (Wetzlar GmbH, Wetzlar, Germany).
The area of new bone formation in the pore of the scaffold was quantitatively measured with BIOQUANT OSTEO II software (R&M Biometrics, Inc, Nashville, Tennessee). This software distinguishes between different tissue fractions based on their individual color spectra, marks them in a specific color, and assigns them to a metric variable that allows for the calculation of different bone indices. As an evaluation parameter, the area of the newly formed bone was calculated in proportion to the area of the pore in the scaffold. Data were gathered from 3 high-powered fields-×40 per specimen-on 4 specimens per group.
Statistical Analysis
The results were reported as mean±standard deviation. A paired t test was performed using SAS version 6.12 software (SAS Institute, Inc, Cary, North Carolina). P<.05 was considered statistically significant.
results
Gross View and Radiographic Examination
All of the sheep had normal diets after implantation of the tissue-engineered bone. Their activity and ability to stand returned to normal approximately 3 weeks postoperatively. All of the sheep survived until the scheduled time of sacrifice without apparent complications such as incision infection, skin necrosis, or fracture. To evaluate bone defect repair and scaffold degradation, radiographs were obtained at 8 and 16 weeks after tissue-engineered bone grafting (Figure 4) . At 8 weeks, the scaffold of ß-TCP was clearly observed on radiographs for all sheep. However, the density of the ß-TCP constructed for the prevascularized tissueengineered bone was lower than that for the nonvascularized tissue-engineered bone. For all of the sheep, the density of ß-TCP was much lower after 16 weeks than after 8 weeks, and the density of the ß-TCP was lower for the prevascularized tissue-engineered bone than for the nonvascularized tissue-engineered bone.
Histological Observation and Histomorphometry
At 8 and 16 weeks postoperatively, samples were extracted for staining with Stevenel blue and van Gieson picrofuchsin (Figure 5) . At 8 weeks, the sections showed that soft tissues had grown into the porous ß-TCP scaffold and a small amount of new bone had formed in both the prevascularized and the nonvascularized groups. In both groups, stained sections showed that more new bones were formed at 16 weeks than at 8 weeks after implantation of the tissue-engineered bone. In the prevascularized group, many vessel-like structures containing numerous red blood cells had formed. The bone tissue was immature around the vessel-like structures, and the mature bone tissue was far from the vessel-like structures 
discussion
Cells play the most important role in the formation of new bone tissues. In numerous studies, tissue-engineered bones have been constructed using single cells with osteogenesis function (eg, BMSCs, adipose-derived stem cells, and embryonic stem cells) to repair bone defects. [15] [16] [17] In addition, sufficient blood supply is necessary for new bone formation. 18 Considering the close relationship between angiogenesis and osteogenesis, neovascularization is an important element in repairing bone defects. 6, 19 Recent studies have used BMSC-derived ECs for vascularization of tissue-engineered bones, with several achieving satisfactory results. [20] [21] [22] [23] Most of these studies used static culture, which limits the survival of seeding cells in the deep parts of the porous scaffold, especially in critical-size scaffolds. In addition, previous studies have focused on the repair of bone defects in small animals such as rats and rabbits. In the current study, the authors constructed prevascularized tissue-engineered bone using BMSC-derived OCs and BMSC-derived ECs in a perfusion bioreactor system to improve the repair of bone defects in sheep.
Radiographs showed that the ß-TCP scaffold was more obvious in the nonvascularized Figure 4 : Radiographs of repairing a bone defect with tissue-engineered bone. The ß-tricalcium phosphate ceramic (ß-TCP) scaffold was still obvious 8 weeks postimplantation of nonvascularized tissue-engineered bone (A) and prevascularized tissue-engineered bone (B). However, the density of the ß-TCP scaffold was slightly lower in the prevascularized group than in the nonvascularized group. At 16 weeks, the density of the ß-TCP scaffold dramatically decreased in both the nonvascularized group (C) and the prevascularized group (D). The density was obviously lower in the prevascularized group than in the nonvascularized group. In addition, the bone defect repair was better in the prevasularized group than in the nonvascularized group. n the cutting edge group than in the prevascularized group at each time point. Furthermore, the normal structure of bone trabeculae could be seen on radiographs in the prevascularized group at 16 weeks postoperatively, with no such structure seen in the nonvascularized group. These findings are in agreement with those previously reported. 8, 11 The results suggested that mature bone tissues had formed in the prevascularized group. Furthermore, the ß-TCP scaffold was absorbed more in the prevascularized group than in the nonvascularized group. This phenomenon may be attributed to the fact that more blood vessels can supply more blood and clear more metabolic products, including the components of the ß-TCP scaffold. In addition, an increased blood supply can transport more macrophages into the porous scaffold to participate in removing the ß-TCP scaffold.
Histological staining showed that more new bone tissues had formed in the prevascularized group than in the nonvascularized group at 8 and 16 weeks postimplantation of the tissueengineered bone. However, new bone formation was dramatically increased in the prevascularized group compared with the nonvascularized group. The area of new bone formation was far greater in the prevascularized group than in the nonvascularized group. These results were in agreement with those previously reported. 24 In addition, in the prevascularized group, some microvessel-like structures containing many red blood cells were found, demonstrating that these structures were connected with preexisting blood vessels around the bone defect. These findings were similar to those of a previous study. 8 These structures may be neovessels formed from BMSC-derived ECs or from preexisting blood vessels around the bone defect. The origin needs to be investigated further.
On the histological sections, new immature bone tissues had formed around the microvessel-like structures, and some mature bone tissues were located far from the microvessel-like structures and around the immature bone tissues. These results suggest that new bone began to form around the neovessels. Thus, the vascularization of the tissue-engineered bone was extremely important for bone defect repair. Moreover, some interactions may be present between the BMSC-derived OCs and the BMSC-derived ECs. Bone marrow mesenchymal stem cell-derived ECs possibly enhanced the osteogenesis of BMSC-derived OCs. Furthermore, signals from ECs may have positively affected the osteogenic potential of BMSCderived OCs, which eventually influenced the maturation of the tissue-engineered bone. Bouletreau et al 25 found that ECs secrete bone morphogenic proteins to promote osteogenesis and stimulate osteoblasts as well as their precursor cells to secrete VEGF. This condition can significantly promote the proliferation of ECs, vascularization, and osteogenesis. 26 Villars et al 27 showed that coculturing MSCs and ECs promotes the proliferative activity of osteoblasts and accelerates the vascularization of tissueengineered bones. Therefore, co-culturing BMSC-derived OCs and BMSC-derived ECs had similar effects.
The current study had 2 major limitations. First, this study only quantified organic matrix. The staining method did not detect bone mineral. Although radiographs detect bone mineral, these observations were not quantified. Second, there was no evaluation of the vascular connection to the host tissue circulation. These issues will be investigated in the future.
conclusion
This study demonstrated that prevascularized tissueengineered bone constructed by co-culturing BMSC-derived OCs and BMSC-derived ECs in porous ß-TCP in a perfusion bioreactor improved vascularization and osteogenesis in vivo. Prevascularized, compared with nonvascularized, tissue-engineered bone mediated by BMSC-ECs could enhance the ability to repair bone defects.
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